ST. LUKES MCCALL — History
CCN 131312 | 3-year financial timeline | COVID resilience: 77/100
🛡️ Public data only — no PHI permitted on this instance.
$47M
Latest Revenue (FY2022)
+12.2%
Revenue CAGR (3yr)
2.5%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $37M | $47M | $47M | -0.4% | +12.2% |
| Operating Expenses | $39M | $41M | $46M | +10.6% | +8.6% |
| Operating Margin | -4.2% | 12.2% | 2.5% | -79.5% | +0.0% |
| Net Income | $-2M | $6M | $1M | -79.5% | +0.0% |
| Licensed Beds | 15 | 15 | 15 | +0.0% | +0.0% |
| Total Patient Days | 1,525 | 1,434 | 1,344 | -6.3% | -6.1% |
| Medicare Day % | 36% | 42% | 42% | -0.9% | +8.0% |
| Medicaid Day % | 14% | 15% | 13% | -11.8% | -4.0% |
COVID Impact & Recovery
Resilience Score: 77/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +25.9% ($37M → $47M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+12.2%
This Hospital
+7.6%
State Avg
Latest Margin
2.5%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $52M | 5.8% |
| FY2024 (proj) | $56M | 9.1% |
| FY2025 (proj) | $61M | 12.5% |